An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666)

Trial Profile

An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666)

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs Gepotidacin (Primary)
  • Indications Gonorrhoea; Respiratory tract infections; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Feb 2014 According to ClinicalTrials.gov record, status changed from active no longer recruiting to completed.
    • 16 Jan 2014 According to ClinicalTrials.gov record, status changed from recruiting to active,no longer recruiting .
    • 16 Jan 2014 According to ClinicalTrials.gov record, planned End Date changed from 1 Dec 2013 to 1 Jan 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top